Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
10.17
+0.51 (5.28%)
At close: Jan 30, 2026, 4:00 PM EST
9.44
-0.73 (-7.20%)
After-hours: Jan 30, 2026, 6:53 PM EST
Biodesix Revenue
Biodesix had revenue of $21.77M in the quarter ending September 30, 2025, with 19.93% growth. This brings the company's revenue in the last twelve months to $80.17M, up 22.29% year-over-year. In the year 2024, Biodesix had annual revenue of $71.32M with 45.30% growth.
Revenue (ttm)
$80.17M
Revenue Growth
+22.29%
P/S Ratio
0.94
Revenue / Employee
$293,674
Employees
273
Market Cap
80.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 71.32M | 22.24M | 45.30% |
| Dec 31, 2023 | 49.09M | 10.88M | 28.46% |
| Dec 31, 2022 | 38.21M | -16.29M | -29.89% |
| Dec 31, 2021 | 54.51M | 8.95M | 19.64% |
| Dec 31, 2020 | 45.56M | 21.01M | 85.55% |
| Dec 31, 2019 | 24.55M | 4.12M | 20.16% |
| Dec 31, 2018 | 20.43M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 825.30M |
| Inotiv | 513.02M |
| FONAR | 105.43M |
| MDxHealth | 103.07M |
| Prenetics Global | 77.08M |
| Burning Rock Biotech | 75.75M |
| Exagen | 63.60M |
| Precipio | 22.80M |
BDSX News
- 20 days ago - Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited) - GlobeNewsWire
- 2 months ago - Biodesix to Present New Data at Two Major Upcoming Scientific Meetings - GlobeNewsWire
- 3 months ago - Biodesix, Inc. (BDSX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Biodesix Announces Third Quarter 2025 Results and Highlights - GlobeNewsWire
- 3 months ago - Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting - GlobeNewsWire
- 3 months ago - Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays - GlobeNewsWire
- 3 months ago - Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 - GlobeNewsWire
- 3 months ago - Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting - GlobeNewsWire